Trending

0

No products in the cart.

0

No products in the cart.

News

CISCE ISC, ICSE Results in January, Students to Receive Scores Only with no merit

The council for the indian School Certificate Examinations (CISCE) is expected to release the result of the Indian Certificate of Secondary education (ICSE) class 10th exam and Indian School Certificate (ISC) class 12 exam on January 1, 2022. CISCE has conducted the first semester of the board exams 2022 for both ICSE and ISC students. The board is expected to release the results of the term 1 examination soon. However, CISCE is yet to make an official announcement in this regard.

Impact of H-1B Visa Changes on IIT-IIM Placements: What to ExpectCareer Challenges

Impact of H-1B Visa Changes on IIT-IIM Placements: What to Expect

The changing landscape of H-1B visas poses challenges and opportunities for IIT-IIM graduates. Discover what to expect in the 2025…

Read More →

Also, CISCE will not release the merit list this time. The final marks will only be revealed after the term 2 exams. The result will be announced after combining the marks of both semester 1 and 2 exams.

CISCE has conducted the first semester of the board exams 2022 for both ICSE and ISC students.

The term 1 results will come in the form of a computer-generated mark sheet. This Mark Sheet will only indicate the marks obtained by the candidates in each subject or paper taken by them for the semester 1 examination, CISCE mentioned in its notification.

Cultivating Leaders: A Two-Way Street to GrowthCareer Development

Cultivating Leaders: A Two-Way Street to Growth

Discover how mentoring others can enhance your own leadership skills, fostering mutual growth in the workplace.

Read More →

Be Ahead

Sign up for our newsletter

Get regular updates directly in your inbox!

Billionaire Hedge Fund Manager Michael Platt Invests in UK Biotech Firm EngitixHealthcare Careers

Billionaire Hedge Fund Manager Michael Platt Invests in UK Biotech Firm Engitix

Billionaire hedge fund manager Michael Platt has invested $25 million in UK biotech firm Engitix to develop therapies for cancer…

Read More →

We don’t spam! Read our privacy policy for more info.

Leave A Reply

Your email address will not be published. Required fields are marked *

Related Posts

You're Reading for Free 🎉

If you find Career Ahead valuable, please consider supporting us. Even a small donation makes a big difference.

Career Ahead TTS (iOS Safari Only)